Variant report
Variant | esv9922 |
---|---|
Chromosome Location | chr11:8199940-8201700 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:8191876..8193485-chr11:8198068..8201621,3 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TUB-1 | chr11:8201638-8201790 | NONHSAT017844 |
2 | lnc-TUB-1 | chr11:8196844-8200450 | ENSG00000246820 |
3 | lnc-TUB-1 | chr11:8196844-8200450 | NONHSAT017845 |
No data |
No data |
Variant related genes | Relation type |
---|---|
TXNL1 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570719350 | chr11:8199966-8199967 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs577351473 | chr11:8199971-8199972 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs539697476 | chr11:8199990-8199991 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs60817303 | chr11:8199993-8199994 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs55850038 | chr11:8199997-8199998 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs572674249 | chr11:8200017-8200018 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs1528123 | chr11:8200018-8200019 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs143597252 | chr11:8200019-8200020 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs138075759 | chr11:8200020-8200021 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs369699964 | chr11:8200024-8200025 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs557074096 | chr11:8200039-8200040 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs566668559 | chr11:8200049-8200050 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs577157720 | chr11:8200054-8200055 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs78084342 | chr11:8200083-8200084 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs553338782 | chr11:8200106-8200107 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs547833549 | chr11:8200128-8200129 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs1528124 | chr11:8200190-8200191 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs541782112 | chr11:8200191-8200192 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs561547465 | chr11:8200197-8200198 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs188377137 | chr11:8200208-8200209 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs5789564 | chr11:8200209-8200210 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs397823986 | chr11:8200212-8200213 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs1528125 | chr11:8200216-8200217 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs372530645 | chr11:8200226-8200227 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs564336210 | chr11:8200243-8200244 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs533389680 | chr11:8200247-8200248 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs546871963 | chr11:8200264-8200265 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs113043558 | chr11:8200266-8200267 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs142536012 | chr11:8200267-8200268 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs180891194 | chr11:8200272-8200273 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs117627469 | chr11:8200316-8200317 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs538335984 | chr11:8200325-8200326 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs370510836 | chr11:8200358-8200359 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs11041785 | chr11:8200363-8200364 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs570648007 | chr11:8200364-8200365 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs184960656 | chr11:8200371-8200372 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs539672275 | chr11:8200394-8200395 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs373931018 | chr11:8200402-8200403 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs553226478 | chr11:8200442-8200443 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs189431870 | chr11:8200475-8200476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs373701321 | chr11:8200478-8200479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555295448 | chr11:8200494-8200495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs182317452 | chr11:8200512-8200513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs186939975 | chr11:8200592-8200593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs191824579 | chr11:8200603-8200604 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533325059 | chr11:8200617-8200618 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs145979745 | chr11:8200618-8200619 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535111133 | chr11:8200628-8200629 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373702508 | chr11:8200629-8200630 | Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs10769883 | chr11:8200635-8200636 | Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 19432969 | CNVD |
Alzheimer''s disease | 17576883 | CNVD |
Long-qt syndrome | 17576883 | CNVD |
Emphysema | 19352772 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Neuroblastoma | 21124317 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Schizophrenia | 21399695 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17160897 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Dysmorphic features | 22052655 | CNVD |
Intellectual disability | 22052655 | CNVD |
Obesity | 22052655 | CNVD |
Prostate cancer | 18632612 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:8198800-8200200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
2 | chr11:8199200-8200200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr11:8200000-8200200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr11:8200000-8200200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr11:8200200-8202000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr11:8200200-8202000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr11:8200600-8200800 | Bivalent Enhancer | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr11:8201600-8202400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |